I have been with Model N as a product manager for last 9 years in the High Tech space. I have an overall experience of 16+ years in the Technology space comprising product manager, product consulting and product engineering roles. I have a keen interest in AI/ML and it has become one of my key focus areas at Model N. I’m looking forward to sharing ideas for solving pressing business problems using AI/ML as an enabler.
Brett DiNatale is the Vice President of Life Science Product Strategy and Management at Model N. Through his 20+ years in life science analytics, Brett’s work has focused on leading teams in forecasting, analytic consulting, data science, and analytic product development. Brett brings this expertise to Model N with responsibility for building the long-term product strategy and roadmap as well as guiding the development of new, analytical offerings. With a deep background in market access, commercialization, and both pre- and post-launch analytic needs, Brett strives to help clients optimize not just their Revenue Management business, but how data enables their strategic decision making overall. Prior to Model N, Brett was SVP, Head of Commercial Analytic Solutions at Precision Medicine Group.
Brian has responsibility to proactively monitor drug pricing reform issues – including legislative, regulatory and administrative actions at the federal and state level – that could impact strategic and business outcomes for McKesson and their customers, partners and other industry stakeholders in the U.S. pharmaceutical value chain. In addition, Brian assesses financial implications for McKesson, and develops strategies and operational solutions to manage risk and drive business value, harnessing the breadth and depth of enterprise assets and capabilities. Brian has been with McKesson for a little over a year and has close to 20 years of pharmaceutical manufacturer experience in government pricing and policy at J&J, Endo Pharmaceuticals and most recently at AstraZeneca. Brian is a subject matter expert in government price reporting that gives him a deep understanding of the U.S. pharmaceutical supply chain, including 340B, buy and bill and diverse payer segments.
Caitlyn Ozier is an FDA & Life Sciences attorney at King & Spalding who regularly counsels pharmaceutical, biotech, and medical device companies on a range of regulatory and compliance matters that impact their sales, marketing, and pricing activities. She has specific expertise counseling life sciences companies on state drug price transparency, prescription drug affordability board, and price gouging laws.
Chanan has been with Model N since 2005 serving in a variety of roles including sales, industry marketing, corporate marketing and corporate development. Chanan served for 7 years as the GM of the High Tech business and currently serves as Senior Vice President of Corporate Strategy. During his time at Model N, Chanan has engaged with over 100 companies’ pricing and channel initiatives. Prior to Model N Chanan was the CEO of Privia Inc. which helped leading Government Contractors such as Lockheed and Boeing manage their bid / and propose sales cycles and prior to that he was the CEO of Click Online which developed consumer multi-media and online products for HP, IBM and The Learning Company. Aside from his 30 year career in Enterprise Software, Chanan is an avid amateur astronomer, served for 6 years as VP and Board Member of the San Mateo Country astronomical society and is an award winning Astro-photographer.
Greg Kwolek is the Vice President of Global Channel Development at Western Digital Corporation. In this role, he focuses on driving the digital transformation of channel marketing, product management, and business management teams. His emphasis on data analytics and data science has led to significant improvements in both the top and bottom lines of the company. Before this position, Mr. Kwolek held various roles in sales, sales operations, and sales strategy at Western Digital and other technology companies. A member of Mensa International, Mr. Kwolek holds a Master’s degree in Business Marketing and Management, has studied Digital Transformation and Data Science, and has received multiple leadership excellence awards.
Imelda Ko has over 8 years of consulting experience across the Life Sciences industry, serving clients including: Gilead, Baxalta, Shire, AstraZeneca, Sanofi-Aventis, Novartis and J&J subsidiaries. Imelda has advised and partnered with clients on gross to net assessments and operational best practices, gross to net forecasting/accruals/close automation solution implementations, pharmaceutical contracting/pricing/market access strategies, revenue management solution implementations (such as Model N Flex), and Government Pricing calculations via BPO support.
Inchul Yoon is a Solutions Architect on the Life Sciences Professional Services team at Model N. With over 11 years of experience at Model N, he has worked directly with top pharmaceutical manufacturers on project implementations of Model N suite products. Inchul has particular expertise in Model N’s script scrubbing solution Validata and also has extensive experience in master data management, chargebacks, and managed care contracting and rebates.
Jasneet Kaur is the Vice President Strategy and Business Development for TE Connectivity’s Channel Business unit, where sales represent approximately 20% of TE’s overall revenue. Jasneet is focused on strengthening our strategic capabilities to drive strategy into action that delivers customer and content growth with TE’s global distribution network. Prior to joining TE in January 2023, Jasneet was with nVent Electric for 17+ years and held various commercial roles. She was Vice President, Business Development at nVent Electric. In this role Jasneet built the organization from the ground-up to deliver scalable growth and a robust pipeline through global channel partnerships and organic and inorganic growth initiatives. In prior commercial roles, Jasneet led go-to market strategy, commercial analytics, digital marketing, and Global Sales and Channel Excellence, developing new markets while building and scaling growth platforms. Jasneet is based in Chicagoland, Illinois, she also likes to volunteer in her free time supporting organizations in helping fund education for the underprivileged kids in India. Jasneet earned her master’s in electrical engineering from IIT, Chicago and her undergraduate in Electronics and Telecommunication Engineering degree from NMU, India.
As Chief Strategy Officer, Jeet is responsible for designing and executing the strategic vision for the company. His role includes developing intellectual property, new product offerings, and key partnerships for scalable growth and innovation across the business. He also serves as the firm’s head of pricing, designing initiatives with executives for breakout profitability growth and overseeing project teams to work collaboratively with clients to improve their market position. Jeet is armed with over two decades of global experience in management consulting, strategy, analytics, marketing, and pricing. He is a regular presenter and keynote speaker, and coaches executives from startups to FORTUNE 100 companies. He specializes in hardware and software pricing with a B2B focus and in 2022, he published Pricing with Confidence: 10 Rules for Increasing Profits and Staying Ahead of Inflation with co-author Reed Holden. Jeet is an Edelman Laureate recipient for his work in business analytics and optimization within distribution. He holds an MBA from Boston University’s Questrom School of Business and has worked with clients in manufacturing, distribution, pharmaceutical, healthcare, and technology sectors.
Jim has 11 years experience in the Managed Markets space and leads the Medicaid Contracting and Rebates team with a focus on process improvements, gross to net insights, and automation updates.
John M. O’Brien, PharmD, MPH, is the president and chief executive officer of the National Pharmaceutical Council (NPC), which sponsors and participates in research on the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation. Dr. O’Brien’s broad experience spans the private sector, academia and government. Prior to NPC, Dr. O’Brien was senior advisor to the U.S. Secretary of Health and Human Services and deputy assistant secretary of planning and evaluation (health policy). He also has held senior policy positions in the life sciences and managed care industries, including at CareFirst BlueCross BlueShield and the Centers for Medicare & Medicaid Services (CMS), and served as a health policy fellow in the U.S. Senate. Dr. O’Brien earned his doctorate in pharmacy at Nova Southeastern University and his master’s degree in public health at the Johns Hopkins Bloomberg School of Public Health.
John Schiavone is a Solution Engineer with 17 years of experience with Model N and over 25 years of experience in the Life Science industry providing technology solutions to business objectives. John has implemented Revenue Management projects for several of the top Pharmaceutical and Med Tech companies and he brings in depth knowledge of contracting, pricing, quoting, rebates, chargebacks, compliance, master data management as well as reporting and analytics. John is currently on the sales team to help customers with their challenges, find solutions to their problems and educate them on the value of Model N Revenue Execution, especially to the Med Tech community.
John Shakow focuses on complex regulatory, commercial, investigation, and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in King & Spalding’s FDA and Life Sciences practice and co-chair of the firm’s Life Sciences & Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation. He has counseled manufacturer clients on their rights and obligations under the Medicaid, 340B, Medicare, Federal Supply Schedule, and TRICARE programs for over 25 years.
With a 20-year career at Advanced Micro Devices, John Stage brings over 10 years in Operations & Supply Chain, working in supply plan optimization, demand / supply matching & data reporting across the entire manufacturing chain (wafer to finished goods). John also has 10 years in Business Intelligence for Business Operations, focus on the data ecosystem for revenue and demand related datasets, visualization & dashboarding in support of demand processes through the value chain and data modeling (Machine Learning & AI) to extrapolate and categorize for business insight. In addition John is the functional business owner for AMD sales tech stack.
With 27 years of experience in international business management and delivery, Jose has established himself as a Senior Principal within the Market Access Center of Excellence, focusing on Global Pricing & Contracting Practice. His expertise spans across the implementation of technology and functional solutions within large and medium-sized pharmaceutical organizations. His areas of specialization include Global Price Management, Tender Management, and Revenue Management, which are critical components in the pharmaceutical industry for ensuring competitive pricing and managing contracts effectively. Jose’s extensive experience and proven track record highlight his capability to navigate complex market dynamics and contribute significantly to the strategic pricing and contracting initiatives.
Joe leads the US Commercial Contracting Team responsible for establishing innovative solutions that support operational excellence in Contract Negotiation, Administration and Pricing Management. Joe brings extensive contracting and pricing experience within the pharmaceutical industry. He joins us from IQVIA, where he was responsible for oversight of the teams providing outsourcing services to Pharma manufacturers including Government Pricing, Managed Care Rebates, Medicaid rebates, Chargebacks, and PMB/Wholesaler audits. Prior to joining IQVIA, Joe spent 16 years working at Novartis in roles of increasing responsibilities managing pharmaceutical contracts covering all aspects of Market Access contract administration. He has built and led teams in the areas of Managed Care and Medicaid rebates, Chargebacks and Membership, Contract negotiation, Federal and State compliance, GTN forecasting, and Strategic Planning.
Jyoti is focused on taking forward the Provider Management and Deal Management products to the next level of growth at Model N. He leverages a combination of Design thinking and lean product Management techniques to create outstanding products. Besides his deep knowledge of Product Management, he leverages his vast experience in Product Development, Consulting and IT to design and build “leading practices” based products. His depth in the Product Management discipline and expertise in building SaaS solutions at scale help in our journey to expand Model N’s portfolio of products. Before Model N, he worked at Icertis – a best of breed, CLM software provider as a Sr. Director of Product Management of Platform and Solutions. Prior to Icertis, Jyoti has had an outstanding career at Oracle in leadership roles for two decades. He led the creation of the Contracts Suite and worked on multiple CX (Marketing, Sales, Service, CPQ, CLM), HCM, Financials and SCM on-premise/Cloud products. He is well versed with Life Sciences, High Tech, Automotive, Financial Services, Retail, Software and Services industries.
With more than 16 years of experience in Life Sciences, Kalyan is currently managing Commercial Finance and Managed Markets operations and solution delivery for some of the largest pharma accounts at Cognizant. In addition, he is also a resident SME for Contracting and Rebate processing in Cognizant’s managed markets practice.
Kevin Suh, Director of Global Commercial Operations at Qualcomm, is a seasoned professional with extensive expertise in the semiconductor industry including Xilinx, Micron, Samsung, and CSR. Specializing in global sales operations and pricing strategy and execution.
Luke Greenwalt is the Vice President of the Market Access Center of Excellence for IQVIA and leads a team of market access specialists across a number of functional areas. He has been in the industry for 20 years and has held a variety of roles ranging from sales to marketing to market access. Luke has firsthand experience launching brands, managing product portfolios, and addressing real world challenges manufacturer’s face as they go to market. He has worked across dozens of clients and is a recognized thought leader in market access with focuses on macroeconomic industry trends, pricing and value, launch excellence, understanding the impact of payer controls on brand performance, patient affordability and copay programs, and gross to net strategies amongst other areas. Luke is an originator and collaborator on over a dozen white papers and frequent speaker on contemporary topics to the life science industry. Luke holds an undergraduate degree from the University of Iowa and an MBA from St Ambrose University, where he graduated summa cum laude.
Matt is responsible for strategy and execution of all aspects of education for the Model N customer and partner communities, including in-app experience with Ngage. We deliver the learning solutions that enable our customers to achieve their goals across their entire journey with us.
Matt is a highly accomplished IT Senior Director with 20+ years of experience in the pharmaceutical industry and currently leads Bayer’s Market Access IT team. He has held a variety of roles from market access IT to fields sales IT. Matt has a proven track record in delivering large capital projects from ideation to business case to go live that include large globally and functionally diverse teams.
Neeraj is a Director in Model N’s Center of Excellence (COE) and the Commercial Practice Lead for the Powered by N application with expertise in Provider and Payer Management. Approaching 20 years working in the commercial life sciences space, with 10+ years implementing Model N solutions at over 30 Life Sciences companies, Neeraj brings a unique perspective that combines a deep understanding of the industry along with extensive knowledge of Model N applications through customer-facing project work. He utilizes his experience and project learning to drive best practices and works closely with product management for future application roadmap considerations. Neeraj also leads an excellent team of talented functional resources supporting commercial Powered by N projects.
Odalys is an innovative and results-oriented Strategic Executive with 30+ years of developing and implementing efficient, cost-effective and innovative business strategies strengthening company operations. She has a proven track record of designing and executing intuitive solutions that promote strategy development and process improvement across commercial, regulatory and financial business segments. Action-oriented Leader with the ability to implement change-management strategies necessary to optimizing available financial resources while maintaining comprehensive compliance and security across domestic and international regulatory bodies. Odalys is actively engaged with Federal and State policy reform. She is a noted leader in the industry promoting inclusion & diversity, development of corporate strategies for strengthening financial methodologies and business integration while achieving unilateral compliance.
Qualified with a hospital pharmacy background and a former Government Adviser to NICE HTA for 10 years, he has been appointed as Visiting Lecturer on Value Based Pricing & Innovative Contracting at the University of Portsmouth. He advises foreign investors (US Embassy) on Value Based Assessments (hosted by the UK Department of Trade & Industry) and recently was invited to address the Italian Healthcare Senate [Senato della Repubblica] on Pharmaco-economic Evaluation & Sustainability Models of Healthcare. At this current time he has embarked on a PhD with his doctorate thesis entitled “Value Based Pricing & Outcomes Based, Innovative Contracting of New Medicines” and his research team has collated a repository of nealry 1000 live innovative contracts across 40 markets. Omar is a single father to 3 daughters, enjoys music (is a keen drummer) and promises to educate & entertain with his unique narrative on medicines, pricing & access from the payer’s perspective!
Pradeesh Bastian has been with Model N since 2007 and is a Sr. Director within Model N Global Customer Success group. Pradeesh manages the Onboarding and Migration Services teams for Model N’s Business Services as well as Model N’s Express customers. In his former roles as Managing Director within Professional Services, Pradeesh managed a large portfolio of small and large customer implementations as well as led Services Sales for these accounts. Prior to joining Model N in 2007, he has worked in the life sciences industry since 2000 in several capacities including Sales Force Effectiveness and Analytics. Pradeesh holds a M.S In Management degree from NJIT and lives in New Jersey.
Rehmann Rayani is Chief Strategy & Marketing Officer and joined Model N in 2018. Rehmann is responsible for leading Model N’s Corporate Strategy function as well as all aspects of the Marketing function across corporate & growth marketing, product marketing, and communications. Rehmann brings 18 years of experience in enterprise software and technology as a strategy and go-to-market leader. Prior to joining Model N, he spent over 4 years at Plex Systems in a variety of senior management roles including VP/GM of the Supply Chain Business Unit and VP of Corporate Strategy. Earlier in his career, Rehmann was a management consultant at Oliver Wyman and an investment associate at ValueAct Capital.
Rehmann holds an MBA from The Wharton School of the University of Pennsylvania and a degree in finance and physics from McGill University.
Rod leads the Contract Operations Team, as part of the US Market Access team. This large multi-functional team is accountable for contracting across all U.S. Payers, leading strategic and compliance activities related to commercial & federal contracting, sales order to cash operations, government reporting, rebate processing, SOx compliance, insights & analytics, and revenue management. He also serves as chairperson for contracting governing bodies and partners with the Government Affairs & Policy team on industry initiatives, legislation, and business impact. Rod is the U.S. Ambassador on the Global Inclusion & Diversity Committee and is a Board Member on the AstraZeneca Political Action Committee. Rod has more than 22 years of pharmaceutical industry experience and leadership. Having been with AstraZeneca for 19 years, Rod has held numerous roles in both Manufacturing Operations, Global Supply Chain, and U.S. Market Access with increased leadership accountability. Prior to coming to AstraZeneca, Rod worked at Merck & Co in Vaccine Operations. Rod graduated from the University of Delaware with a Bachelor of Science in Medical Technology. Rod is passionate about creating an inclusive environment that drives value for the organization and the patients we serve.
Ms. White is an Engagement Manager at IQVIA within the Global Pricing & Contracting (GPC) Practice. She has 30 years of consulting experience, and over 20 years of experience managing testing.
Sarah Morgan serves as the Corporate Vice President of Business Management at AMD, leading the Sales & Business Operations team with over a decade of experience in various roles within the company. Prior to her tenure at AMD, she worked across Finance, Sales, and HR in industries such as Oil & Gas, Financial Services, and Consumer Packaged Goods. In her current role, Sarah oversees initiatives related to Revenue Attainment, Sales Planning & Targeting, and managing key business applications like Salesforce (CRM) and Pricing Solutions. She holds an MBA from Texas A&M University and a Bachelor of Science degree from Baylor University, grounding her strategic leadership in a solid educational background.
Sarath has 19 years of experience in the industry, with a notable focus on Managed Market practice. As a solution architect in Cognizant, he specializes in Commercial space and SaaS migration, leveraging his expertise to streamline processes and optimize outcomes along with managing delivery for some of the pharma accounts.
Sera (Serafina) Oxner brings 40 plus years of experience in the pharmaceutical industry. She started her career with Schering-Plough Corporation (now part of Merck) leading in both International and Domestic finance organizations within Pharmaceuticals, Generic and Consumers Product Divisions. Sera then joined Novartis leading Managed Market Finance teams in the US and India. Sera has gained extensive Managed Markets experience with both companies and was previously a customer of Model N through multiple implementations. She now joins Model N as VP, Business Services.
Shawna joined Model N in 2021 as an Associate Education Consultant among the Education Services team. She enjoys working on customer engagements through trainings and eLearning projects.
Shawn has worked for Model N for over 7 years in Professional Services. Shawn joined Model N in 2016 and spent 6 years managing projects and is now on the Services Sales team.
Srilekha Ramesh Kumar is a Principal in IQVIA’s Global Pricing and Contracting (IQVIA GPC) practice with almost 15 years of experience supporting Revenue Management teams across the Life Sciences. Srilekha has experience spanning from early implementations of Model N Flex to creating Custom GP Applications to large scale Cloud Implementations supporting clients of all sizes and portfolios. Her expertise lies mostly with Government Pricing and has been instrumental in supporting advanced pricing models while adhering to Organizational compliance and audit requirements. Srilekha has a keen interest in Government Contracts, FSS and Gross to Net and is skilled in performing market research for devising pricing strategies and developing standardized methodologies / approaches for analyzing pricing models. Having led overall solution design for several large life science companies based on their M&A activity, she is well equipped to support manufacturers merging, acquiring, or divesting brands/divisions. Beyond product implementations and designing custom cloud applications in market access areas, Srilekha is a trusted advisor to clients for strategic review of operational and organizational design.
Sastry manages multiple large pharma accounts for Cognizant and is responsible for service delivery. He also plays the lead for Cognizant’s managed markets practice, where he stewards business growth. With 20+ years of experience in Life Sciences and heath care, he brings a data centric approach to solution design and problem solving.
Tom has been with Model N for eight years and is responsible for defining projects and writing SOWs for new and existing customers in both the Life Sciences and High Tech markets. In his previous role as Engagement Manager, he led projects for new customer implementations, major version upgrades, customer expansions, SaaS transitions and ERP migrations. Prior to joining Model N he was an IT leader at two Fortune 500 companies and earned his MBA from the University of Minnesota. He lives with his wife in St. Paul, Minnesota, and has two daughters who are recent college graduates.
Vijay leads Model N HT Professional Services and Channel Data Management operations team. I joined Model N 11 years back. For the initial 5 years I led Model N Europe customer success practice for both Life Sciences and High Tech Verticals. Before joining Model N, I worked at SAP for 10 years and led go-to-market activities for SAP SaaS Solutions.
With more than 25 years of experience across Strategy Consulting, Innovation, Branding & Marketing Operations, Vyom leads Cognizant’s LS Commercial practice and advises leading pharma and life sciences clients on their large-scale digital transformation programs.
Experience Market Access professional specializing in vaccines and pricing strategy.
Will Tenneson has been working in the digital product optimization space for 10 years – continually focused on using data to improve experiences. He now works with Pendo’s largest customers to ensure value realization in their program – spanning from program value structure to metric measurement to tactical strategy to achieve goals.